217 related articles for article (PubMed ID: 36969161)
41. Immune cell infiltration and immunotherapy in hepatocellular carcinoma.
Jiang Y; Lin L; Lv H; Zhang H; Jiang L; Ma F; Wang Q; Ma X; Yu S
Math Biosci Eng; 2022 May; 19(7):7178-7200. PubMed ID: 35730302
[TBL] [Abstract][Full Text] [Related]
42. Prediction of lung squamous cell carcinoma immune microenvironment and immunotherapy efficiency with pyroptosis-derived genes.
Deng X; Wang Z; Luo Y; Li Z; Chen L
Medicine (Baltimore); 2022 Sep; 101(37):e30304. PubMed ID: 36123889
[TBL] [Abstract][Full Text] [Related]
43. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
[TBL] [Abstract][Full Text] [Related]
44. Identification of key immune cell-related genes involved in tumorigenesis and prognosis of cervical squamous cell carcinoma.
Yan C; Ma Y; Li J; Chen X; Ma J
Hum Vaccin Immunother; 2023 Aug; 19(2):2254239. PubMed ID: 37799074
[TBL] [Abstract][Full Text] [Related]
45. Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma.
Fan T; Pan S; Yang S; Hao B; Zhang L; Li D; Geng Q
Front Immunol; 2021; 12():693062. PubMed ID: 34497605
[TBL] [Abstract][Full Text] [Related]
46. Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer.
Qiu P; Guo Q; Yao Q; Chen J; Lin J
Front Immunol; 2021; 12():736030. PubMed ID: 34659224
[TBL] [Abstract][Full Text] [Related]
47. Pan-cancer analysis identifies migrasome-related genes as a potential immunotherapeutic target: A bulk omics research and single cell sequencing validation.
Qin Y; Yang J; Liang C; Liu J; Deng Z; Yan B; Fu Y; Luo Y; Li X; Wei X; Li W
Front Immunol; 2022; 13():994828. PubMed ID: 36405728
[TBL] [Abstract][Full Text] [Related]
48. Characteristics of Ovarian Cancer Immune Cell Invasion and Bioinformatics to Predict the Effect of Immunotherapy.
Yan L; Fan E; Tan B
Horm Metab Res; 2024 Mar; 56(3):197-205. PubMed ID: 38242159
[TBL] [Abstract][Full Text] [Related]
49. A Four-Cell-Senescence-Regulator-Gene Prognostic Index Verified by Genome-Wide CRISPR Can Depict the Tumor Microenvironment and Guide Clinical Treatment of Bladder Cancer.
Sun JX; Liu CQ; Xu JZ; An Y; Xu MY; Zhong XY; Zeng N; Ma SY; He HD; Zhang ZB; Wang SG; Xia QD
Front Immunol; 2022; 13():908068. PubMed ID: 35898492
[TBL] [Abstract][Full Text] [Related]
50. Development and Validation of a TNF Family-Based Signature for Predicting Prognosis, Tumor Immune Characteristics, and Immunotherapy Response in Colorectal Cancer Patients.
Xiao Z; Nie K; Han T; Cheng L; Zhang Z; Peng W; Shi D
J Immunol Res; 2021; 2021():6439975. PubMed ID: 34541005
[TBL] [Abstract][Full Text] [Related]
51. Identification of molecular subtypes premised on the characteristics of immune infiltration of endometrial cancer.
Liu C; Zhang Y; Hang C
Ann Transl Med; 2022 Mar; 10(6):337. PubMed ID: 35433941
[TBL] [Abstract][Full Text] [Related]
52. Multiomics profiling reveals the benefits of gamma-delta (γδ) T lymphocytes for improving the tumor microenvironment, immunotherapy efficacy and prognosis in cervical cancer.
Li J; Cao Y; Liu Y; Yu L; Zhang Z; Wang X; Bai H; Zhang Y; Liu S; Gao M; Lu C; Li C; Guan Y; Tao Z; Wu Z; Chen J; Yuan Z
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38199610
[TBL] [Abstract][Full Text] [Related]
53. Signature involved in immune-related lncRNA pairs for predicting the immune landscape of cervical cancer.
Liu X; Wang Z; Wang L; Wang Y; Wang Y; Yang S; Zhang Y
Int J Biol Markers; 2022 Jun; 37(2):191-199. PubMed ID: 35435763
[TBL] [Abstract][Full Text] [Related]
54. CD48 suppresses proliferation and migration as an immune-related prognostic signature in the cervical cancer immune microenvironment.
Ma Y; Yang Z; Liu J; Wang D
Carcinogenesis; 2024 Feb; 45(1-2):57-68. PubMed ID: 37279525
[TBL] [Abstract][Full Text] [Related]
55. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Zhang X; Shi X; Zhao H; Jia X; Yang Y
Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
[TBL] [Abstract][Full Text] [Related]
56. m6A Regulator-Mediated Tumour Infiltration and Methylation Modification in Cervical Cancer Microenvironment.
Zhang W; Xiao P; Tang J; Wang R; Wang X; Wang F; Ruan J; Yu S; Tang J; Huang R; Zhao X
Front Immunol; 2022; 13():888650. PubMed ID: 35572541
[TBL] [Abstract][Full Text] [Related]
57. Tumor microenvironment characterization in cervical cancer identifies prognostic relevant gene signatures.
Peng L; Hayatullah G; Zhou H; Chang S; Liu L; Qiu H; Duan X; Han L
PLoS One; 2021; 16(4):e0249374. PubMed ID: 33901225
[TBL] [Abstract][Full Text] [Related]
58. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
[TBL] [Abstract][Full Text] [Related]
59. Identification of Immune Cell Infiltration Landscape and Their Prognostic Significance in Uveal Melanoma.
Zhao H; Chen Y; Shen P; Gong L
Front Cell Dev Biol; 2021; 9():713569. PubMed ID: 34513843
[TBL] [Abstract][Full Text] [Related]
60. Genomic and immunogenomic analysis of three prognostic signature genes in LUAD.
Feng HM; Zhao Y; Yan WJ; Li B
BMC Bioinformatics; 2023 Jan; 24(1):19. PubMed ID: 36650426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
